21st June 2023
HWS: The Need for Diversity in Clinical Trials – And why the Middle East could be part of the answer
With 90% of the world’s clinical trials taking place on Western, Caucasian patient groups, what are the potential consequences of failing to undertake testing on regional, ethnic groups? Join Healthcare World and our panel of experts from across the Middle East to find out what steps can be taken to mitigate this situation.
This session is sponsored by:
Speakers in this session:
Contribute to this session:
Mike Failly
Managing Director, Zanteris
Dr. Ibtesam Al Bastaki
Director of Investment and PPP department, Dubai Health Authority
Hinda Daggag
Corporate Head of Genetics, SEHA
Raesa Afzal
Senior Counsel, Al Tamimi
Mansoor Ahmed
Executive Director, Colliers